Yoni Goldwasser

Yoni Goldwasser is based in Berlin. His Crunchbase bio reads: "Princeton, Harvard, MIT, BCG >> corporate, consulting, entrepreneurship, venture development, VC. Live in Berlin. AI + Healthcare = Magic." He holds a BA in Chemistry from Princeton (2000 to 2004) and a PhD in Medical Engineering from the Harvard-MIT Division of Health Sciences and Technology (2004 to 2010). His early research at the Center for Engineering in Medicine focused on viruses, both as pathogens and as gene delivery vectors.

His career runs through pharma, consulting and startups. Wellfound lists him at Boston Consulting Group from 2011 to 2013 and at Teva Pharmaceutical Industries. He was co-founder and CEO of OhTell from 2014 to 2015, according to Wellfound and ContactOut. ContactOut also lists him as a principal at Goldmed Ltd. from 2015 to 2018. The Springboard Health Angels site says he co-founded Nym Health.

From 2018 to 2020 he was Director of Venture Development at APX, the Berlin early-stage investor and accelerator backed by Axel Springer and Porsche. There he led the Digital Health Initiative, which he describes as aiming to bridge the gap between innovation and commercialization in digital health in Berlin and Germany. ContactOut and RocketReach list him as its founder from 2020 to 2023. In the same period they list him as an expert evaluator for EIT Health Germany (2021 to 2023), a senior advisor to the Berlin Institute of Health's Digital Health Accelerator (2020 to 2023) and a lecturer at ESCP Business School. Since 2022 he has been a founder and managing director at Springboard Health Angels, alongside co-founder and managing director Andreas Schmidt.

Crunchbase lists 3 investments by Yoni Goldwasser personally, in 3 portfolio companies. It records no lead investments and no exits, and 1 company founded. The three rounds are a pre-seed in Mirantus Health and seed rounds in Vivalyx and YonedaLabs. Crunchbase shows the Vivalyx and YonedaLabs round announcements in April 2024.

His angel activity is larger than that Crunchbase record suggests, because much of it runs through Springboard Health Angels. Crunchbase describes Springboard as an angel syndicate of industry insiders investing in healthcare and health tech globally. At a 2025 Mind the Tech Berlin HealthTech roundtable reported by Calcalist, he said he had founded several companies and recently formed a group of investors. He said the group had invested in around 30 companies, focusing on special deals. That figure is his own statement and has not been checked against a portfolio list.

His stated interest in AI sits mainly within healthcare. A Cybertech Israel speaker bio says he has a keen interest in digital health, specifically at the interface of AI. That interest led him to co-found the Digital Health Initiative in Berlin. His Crunchbase bio puts it as "AI + Healthcare = Magic."

NFX Signal ranks him among AI investors at pre-seed and seed, next to his digital health, diagnostics and medical device rankings. No public source found for this page names a specific AI company he backed, with a year. YonedaLabs lists Y Combinator among its investors and is based in San Francisco. This page does not describe its product, because the sources reviewed do not.

Stage: NFX Signal lists him at pre-seed and seed. Data aggregators such as Shizune list the same stages, and EasyVC also adds Series A. These are third-party classifications rather than his own statements.

Sectors: his work centers on healthcare and health tech. NFX Signal lists digital health, health IT, diagnostics, therapeutics, pharmaceuticals, medical devices, and health and hospital services, plus AI. Springboard Health Angels describes its focus as healthcare and health tech.

Geography: he is based in Berlin and works across the US, Israel and Germany, according to the Springboard bio. Shizune lists Germany and the United States as investment geographies. In the 2025 Calcalist roundtable he took part in a discussion on Israeli healthtech companies working with German hospitals, insurers and investors. He has also written on the differences between the Tel Aviv and Berlin startup ecosystems.

Check size: NFX Signal lists an investment range of $15K to $100K, with a sweet spot of $30K. Treat this as an estimate from a third-party platform. He has not published a check size on a personal site that we found.

• Vivalyx: seed round listed on Crunchbase, with the round announced in April 2024. Crunchbase does not mark him as lead.
• YonedaLabs: seed round listed on Crunchbase, with the round announced in April 2024. Crunchbase lists Y Combinator among its 11 investors and he is not marked as lead.
• Mirantus Health: pre-seed round listed on Crunchbase, with Springboard Health Angels also listed as an investor. The date is not shown publicly.
• Nym Health: co-founded by him, according to the Springboard Health Angels team page. This is a founding role, not an investment.

• crunchbase.com/person/yoni-goldwasser
• signal.nfx.com/investors/dr-yoni-goldwasser
• springboardangels.com/team/dr.-yoni-goldwasser
• crunchbase.com/organization/springboard-health-angels
• calcalistech.com/ctechnews/article/dljd43ehh
• cybertechisrael.com/node/1006
• the-berliner.com/berlin/yoni-goldwasser-interview-apx
• wellfound.com/p/yonigoldwasser